引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1795次   下载 2419 本文二维码信息
码上扫一扫!
分享到: 微信 更多
TAK免疫增强剂对奶牛乳房炎的疗效观察
陈德坤1, 雷莉辉1, 朱 辉1
西北农林科技大学 动物科技学院
摘要:
根据临床症状及应用亚临床乳房炎快速诊断试验检出试验用奶牛。将确诊的泌乳期临床乳房炎奶牛10头设为A组,干奶期临床乳房炎奶牛8头设为B组, 泌乳期隐性乳房炎奶牛18头设为C组,C组中另设肌肉注射组(肌注组6头)、乳房注射组(乳注组6头)及对照组(6头)。用TAK免疫增强剂进行治疗试验,A,B组的给药途径为肌肉注射,每次每头10 mL/d;C组肌注组给药方法同A,B组,乳注组在每个患病奶牛乳区注射,剂量为每乳每区10 mL/d。临床乳房炎治愈效果以患病奶牛临床症状消失作为主要指标,隐性乳房炎奶牛采用称量法测定每头奶牛不同时期的日均泌乳量,并用BMT诊断液检测治疗效果。治疗试验结果表明,TAK免疫增强剂对临床乳房炎特别是泌乳期临床乳房炎奶牛治愈率达80%,对干奶期奶牛治愈率为37.5%,对隐性乳房炎奶牛也有较好的疗效,尤其可使肌注组奶牛产奶量明显增加,且肌注组和乳注组乳头阳性率分别比治疗前下降了21.6%和16.7%。
关键词:  奶牛乳房炎  TAK免疫增强剂  疗效
DOI:
分类号:
基金项目:陕西省农业重点推广项目(农发办59)
Treatment effects of TAK immune regulator on dairy milk cow with cow mastistis
Abstract:
Milk cow with mastitis were sorted out according to clinical symptoms and Beijing mastitis test(BMT).Ten milking cows with clinical mastitis were classified into A group,and eight stop-milking cows with clinical mastitis were sorted into B group,and eighteen milk cows with subclinical mastitis were categorized into C group.All milk cows in A and B groups were treated with TAK immune regulator by muscular injection.In C group,six milk cows were treated in the same way with those in A and B group,and six milk cows were treated by teat canal injection,and six milk cows were not treated.The injected dosage per milk cow is 10ml per day.The results show that,after being treated with TAK immune regulator,8 out of 10 milking cow’s typical mastitis symptoms were disappeared,and 3 out of 8 stop-milking cow’s typical mastitis symptoms were disappeared,and the mastitis rates of milk cow quarters treated in C group have dropped 16.7% and 21.6% on an average in canal injection milk cows and muscular injection milk cows respectively compared with those not treated milk cows.In addition,the milk production of those cows in C group treated by muscular injection have increased remarkably compared with those not treated milk cow.
Key words:  cow mastitis  TAK immune regulator  treatment effect